CRSP
CRISPR Therapeutics AG
Latest News for CRSP
Crispr Therapeutics AG ( ($CRSP) ) has fallen by -9.20%. Read on to learn why. Crispr Therapeutics AG has experienced a notable decline in its stoc......
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 20, as revealed in daily fun......
Crispr Therapeutics ( ($CRSP) ) has released its Q3 earnings. Here is a breakdown of the information Crispr Therapeutics presented to its investors......
In a report released today, from Oppenheimer maintained a Buy rating on Crispr Therapeutics AG, with a price target of $95.00. In addition to Oppen......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Perspective Therapeutics (CATX – Research Report), C......
Barclays analyst Gena Wang maintained a Hold rating on Crispr Therapeutics AG today and set a price target of $56.00. According to TipRanks, Wang i......
Looking for top-rated stocks to buy now? Based on recent analyst updates, the three companies below have all earned Strong Buy ratings from Top Wal......
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several trades for Tuesday, November 4, 2025, highlighting new buys in biotech stock......
Crispr Therapeutics AG ( ($CRSP) ) has fallen by -8.60%. Read on to learn why. Crispr Therapeutics AG has experienced a notable decline in its stoc......
News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRSP | $50.23 | +1.9% | 2.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |